These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28031408)

  • 1. Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC.
    Güttlein LN; Benedetti LG; Fresno C; Spallanzani RG; Mansilla SF; Rotondaro C; Raffo Iraolagoitia XL; Salvatierra E; Bravo AI; Fernández EA; Gottifredi V; Zwirner NW; Llera AS; Podhajcer OL
    Mol Cancer Res; 2017 Mar; 15(3):304-316. PubMed ID: 28031408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of secreted protein acidic and rich in cysteine expression in breast cancer tissue and its association with prognosis.
    Guo W; Zhang M; Chen Y; Guo S
    J Cancer Res Ther; 2017; 13(5):833-836. PubMed ID: 29237913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment.
    Alcaraz LB; Mallavialle A; David T; Derocq D; Delolme F; Dieryckx C; Mollevi C; Boissière-Michot F; Simony-Lafontaine J; Du Manoir S; Huesgen PF; Overall CM; Tartare-Deckert S; Jacot W; Chardès T; Guiu S; Roger P; Reinheckel T; Moali C; Liaudet-Coopman E
    Theranostics; 2021; 11(13):6173-6192. PubMed ID: 33995652
    [No Abstract]   [Full Text] [Related]  

  • 5. Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model.
    Riabov V; Yin S; Song B; Avdic A; Schledzewski K; Ovsiy I; Gratchev A; Llopis Verdiell M; Sticht C; Schmuttermaier C; Schönhaber H; Weiss C; Fields AP; Simon-Keller K; Pfister F; Berlit S; Marx A; Arnold B; Goerdt S; Kzhyshkowska J
    Oncotarget; 2016 May; 7(21):31097-110. PubMed ID: 27105498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
    Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
    Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes.
    Watkins G; Douglas-Jones A; Bryce R; Mansel RE; Jiang WG
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):267-72. PubMed ID: 15763438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
    Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
    J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.
    Wong SY; Crowley D; Bronson RT; Hynes RO
    Clin Exp Metastasis; 2008; 25(2):109-18. PubMed ID: 18058030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis.
    Defresne F; Bouzin C; Grandjean M; Dieu M; Raes M; Hatzopoulos AK; Kupatt C; Feron O
    Cancer Res; 2011 Jul; 71(14):4748-57. PubMed ID: 21616936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
    Koblinski JE; Kaplan-Singer BR; VanOsdol SJ; Wu M; Engbring JA; Wang S; Goldsmith CM; Piper JT; Vostal JG; Harms JF; Welch DR; Kleinman HK
    Cancer Res; 2005 Aug; 65(16):7370-7. PubMed ID: 16103089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
    Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
    Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype.
    Majorini MT; Cancila V; Rigoni A; Botti L; Dugo M; Triulzi T; De Cecco L; Fontanella E; Jachetti E; Tagliabue E; Chiodoni C; Tripodo C; Colombo MP; Lecis D
    Cancer Res; 2020 Jun; 80(11):2311-2324. PubMed ID: 32179512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
    Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
    Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
    Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
    J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
    Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EK; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ
    Cancer Res; 2013 Jul; 73(14):4474-87. PubMed ID: 23720052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human endoplasmic reticulum oxidoreductin 1-α is a novel predictor for poor prognosis of breast cancer.
    Kutomi G; Tamura Y; Tanaka T; Kajiwara T; Kukita K; Ohmura T; Shima H; Takamaru T; Satomi F; Suzuki Y; Torigoe T; Sato N; Hirata K
    Cancer Sci; 2013 Aug; 104(8):1091-6. PubMed ID: 23578220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
    Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
    Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer.
    Chen J; Wang M; Xi B; Xue J; He D; Zhang J; Zhao Y
    PLoS One; 2012; 7(8):e42413. PubMed ID: 22879971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.